Latest On Vir Biotechnology, Inc (VIR):
About Vir Biotechnology, Inc (VIR):
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus; and VIR-2020 for the prevention of tuberculosis. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; a collaboration, license, and option agreement with Visterra, Inc.; license agreements with The Rockefeller University and MedImmune, Inc.; a collaboration with WuXi Biologics; and a collaborative research agreement with Generation Bio., as well as GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline Biologicals SA., and Alnylam Pharmaceuticals, Inc. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies for potential COVID-19 treatment; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. Vir Biotechnology, Inc. was founded in 2016 and is headquartered in San Francisco, California.
General
- Name Vir Biotechnology, Inc
- Symbol VIR
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 327
- Fiscal Year EndDecember
- IPO Date2019-10-11
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Web URLhttp://www.vir.bio
Valuation
- Price/Sales (Trailing 12 Mt.) 82.42
- Price/Book (Most Recent Quarter) 9.42
- Enterprise Value Revenue 79.69
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.31
- Next Year EPS Estimate -$0.72
- Next Quarter EPS Estimate -$0.69
- Operating Margin -350%
- Return on Assets -23%
- Return on Equity -52%
- Revenue 76.37 million
- Earnings Per Share -$5.76
- Revenue Per Share $0.64
- Gross Profit -196511000
- Quarterly Earnings Growth 76.9%
Highlights
- Market Capitalization 7.18 billion
- EBITDA -126076000
- PE Ratio -1.8
- Analyst Target Price $88.4
Share Statistics
- Shares Outstanding 127.39 million
- Shares Float 60.51 million
- % Held by Insiders 1416%
- % Held by Institutions 79.61%
- Shares Short 8.11 million
- Shares Short Prior Month 8.44 million
- Short Ratio 3.32
- Short % of Float 13%
- Short % of Shares Outstanding 6%
Technicals
- 52 Week High $83.5
- 52 Week Low $25.31
- 50 Day Moving Average 62.25
- 200 Day Moving Average 40.67
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Vir Biotechnology, Inc (VIR) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Vir Biotechnology, Inc (VIR) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2021-02-25 | $N/A | -$0.83 | -$0.70 | -18.86% |
2020-09-30 | 2020-11-10 | $N/A | -$0.67 | -$0.60 | -12.02% |
2020-06-30 | 2020-08-11 | $66.99 million | -$0.27 | -$0.62 | 56.19% |
2020-03-31 | 2020-05-12 | $5.72 million | -$0.71 | -$0.56 | -27.51% |
2019-12-31 | 2020-03-26 | $980000 | -$0.69 | -$0.63 | -10.1% |
2019-09-30 | 2019-11-19 | $1.4 million | -$4.60 | -$3.34 | -37.93% |
Vir Biotechnology, Inc (VIR) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Vir Biotechnology, Inc (VIR) Chart:
Vir Biotechnology, Inc (VIR) News:
Below you will find a list of latest news for Vir Biotechnology, Inc (VIR) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Vir Biotechnology, Inc (VIR) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|---|---|---|---|---|---|---|---|---|
2024-05-17 | 2.5 | 0 | CALL | 0 | 0 | 514.84 | TRUE | 0 | 0 |
2024-05-17 | 5 | 3.46 | CALL | 0 | 2 | 226.12 | TRUE | 0 | 0 |
2024-05-17 | 7.5 | 0.88 | CALL | 0 | 19 | 85.95 | TRUE | 0 | 0 |
2024-05-17 | 10 | 0.05 | CALL | 1 | 233 | 59.95 | FALSE | 0 | 0 |
2024-05-17 | 12.5 | 0.25 | CALL | 0 | 503 | 0 | FALSE | 0 | 0 |
2024-05-17 | 15 | 0.2 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
2024-05-17 | 17.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 20 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 22.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 7.5 | 0.34 | PUT | 7 | 122 | 66.31 | FALSE | -0.06 | -0.15 |
2024-05-17 | 10 | 1.84 | PUT | 0 | 152 | 83.55 | TRUE | 0 | 0 |
2024-05-17 | 12.5 | 0 | PUT | 0 | 0 | 188.26 | TRUE | 0 | 0 |
2024-05-17 | 15 | 0 | PUT | 0 | 0 | 242.65 | TRUE | 0 | 0 |
2024-05-17 | 17.5 | 0 | PUT | 0 | 0 | 237.66 | TRUE | 0 | 0 |
2024-05-17 | 20 | 0 | PUT | 0 | 0 | 220.22 | TRUE | 0 | 0 |
2024-05-17 | 22.5 | 0 | PUT | 0 | 0 | 289.78 | TRUE | 0 | 0 |
2024-06-21 | 2.5 | 0 | CALL | 0 | 0 | 262.94 | TRUE | 0 | 0 |
2024-06-21 | 5 | 0 | CALL | 0 | 0 | 195.63 | TRUE | 0 | 0 |
2024-06-21 | 7.5 | 0.9 | CALL | 0 | 20 | 63.25 | TRUE | 0 | 0 |
2024-06-21 | 10 | 0.3 | CALL | 8 | 5 | 64.7 | FALSE | 0.3 | 0 |
2024-06-21 | 12.5 | 0.09 | CALL | 0 | 1 | 74.05 | FALSE | 0 | 0 |
2024-06-21 | 15 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-06-21 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-06-21 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-06-21 | 7.5 | 0 | PUT | 0 | 0 | 55.41 | FALSE | 0 | 0 |
2024-06-21 | 10 | 0 | PUT | 0 | 0 | 61.7 | TRUE | 0 | 0 |
2024-06-21 | 12.5 | 0 | PUT | 0 | 0 | 101.49 | TRUE | 0 | 0 |
2024-06-21 | 15 | 0 | PUT | 0 | 0 | 151.36 | TRUE | 0 | 0 |
2024-07-19 | 2.5 | 6.6 | CALL | 0 | 4 | 182.29 | TRUE | 0 | 0 |
2024-07-19 | 5 | 6.1 | CALL | 0 | 5 | 98.67 | TRUE | 0 | 0 |
2024-07-19 | 7.5 | 1.1 | CALL | 10 | 125 | 86.16 | TRUE | 0.1 | 0.1 |
2024-07-19 | 10 | 0.3 | CALL | 0 | 554 | 63.07 | FALSE | 0 | 0 |
2024-07-19 | 12.5 | 0.2 | CALL | 0 | 1272 | 66.38 | FALSE | 0 | 0 |
2024-07-19 | 15 | 0.08 | CALL | 20 | 115 | 74.65 | FALSE | 0.08 | 0 |
2024-07-19 | 17.5 | 0.3 | CALL | 0 | 151 | 0 | FALSE | 0 | 0 |
2024-07-19 | 20 | 0.15 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
2024-07-19 | 22.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-07-19 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-07-19 | 5 | 0.15 | PUT | 0 | 28 | 0 | FALSE | 0 | 0 |
2024-07-19 | 7.5 | 0.7 | PUT | 0 | 1331 | 71.38 | FALSE | 0 | 0 |
2024-07-19 | 10 | 1.95 | PUT | 0 | 88 | 63.4 | TRUE | 0 | 0 |
2024-07-19 | 12.5 | 2.15 | PUT | 0 | 109 | 75.06 | TRUE | 0 | 0 |
2024-07-19 | 15 | 4.2 | PUT | 0 | 1 | 121.86 | TRUE | 0 | 0 |
2024-07-19 | 17.5 | 0 | PUT | 0 | 0 | 126.08 | TRUE | 0 | 0 |
2024-07-19 | 20 | 0 | PUT | 0 | 0 | 156.48 | TRUE | 0 | 0 |
2024-07-19 | 22.5 | 0 | PUT | 0 | 0 | 203.34 | TRUE | 0 | 0 |
2024-10-18 | 2.5 | 0 | CALL | 0 | 0 | 168.49 | TRUE | 0 | 0 |
2024-10-18 | 5 | 0 | CALL | 0 | 0 | 95.67 | TRUE | 0 | 0 |
2024-10-18 | 7.5 | 1.85 | CALL | 1 | 3 | 63.15 | TRUE | 1.85 | 0 |
2024-10-18 | 10 | 0.85 | CALL | 1 | 146 | 60.62 | FALSE | 0.85 | 0 |
2024-10-18 | 12.5 | 0.4 | CALL | 0 | 152 | 66.82 | FALSE | 0 | 0 |
2024-10-18 | 15 | 0.25 | CALL | 8 | 217 | 66.52 | FALSE | 0.25 | 0 |
2024-10-18 | 17.5 | 0.5 | CALL | 0 | 9 | 71.29 | FALSE | 0 | 0 |
2024-10-18 | 20 | 0.1 | CALL | 0 | 605 | 71.53 | FALSE | 0 | 0 |
2024-10-18 | 22.5 | 0.29 | CALL | 0 | 51 | 0 | FALSE | 0 | 0 |
2024-10-18 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-10-18 | 5 | 0 | PUT | 0 | 0 | 71.07 | FALSE | 0 | 0 |
2024-10-18 | 7.5 | 1.1 | PUT | 0 | 44 | 67.26 | FALSE | 0 | 0 |
2024-10-18 | 10 | 1.36 | PUT | 0 | 27 | 62.38 | TRUE | 0 | 0 |
2024-10-18 | 12.5 | 3.55 | PUT | 0 | 6 | 72.32 | TRUE | 0 | 0 |
2024-10-18 | 15 | 0 | PUT | 0 | 0 | 89.86 | TRUE | 0 | 0 |
2024-10-18 | 17.5 | 0 | PUT | 0 | 0 | 106.83 | TRUE | 0 | 0 |
2024-10-18 | 20 | 0 | PUT | 0 | 0 | 129.9 | TRUE | 0 | 0 |
2024-10-18 | 22.5 | 0 | PUT | 0 | 0 | 125.73 | TRUE | 0 | 0 |
Latest VIR Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:59 PM EST | 1 | $22.11 |
Jun 13, 2022 7:59 PM EST | 3 | $22.13 |
Jun 13, 2022 7:59 PM EST | 100 | $22.12 |
Jun 13, 2022 7:59 PM EST | 100 | $22.11 |
Jun 13, 2022 7:59 PM EST | 11 | $22.09 |
Vir Biotechnology, Inc (VIR) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120040664/0001209191-20-040664-index.htm |
2020-06-29 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1706431/000000000020005785/0000000000-20-005785-index.htm |
2019-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000089843219001252/0000898432-19-001252-index.htm |
2019-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000089843219001253/0000898432-19-001253-index.htm |
2019-12-05 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1706431/000089843219001340/0000898432-19-001340-index.htm |
2020-05-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1706431/000089843220000544/0000898432-20-000544-index.htm |
2019-10-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000089924319025486/0000899243-19-025486-index.htm |
2019-10-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000089924319025488/0000899243-19-025488-index.htm |
2019-10-16 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000089924319025640/0000899243-19-025640-index.htm |
2019-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000089924319025695/0000899243-19-025695-index.htm |
2019-10-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000089924319025766/0000899243-19-025766-index.htm |
2019-10-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000089924319025772/0000899243-19-025772-index.htm |
2019-10-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000090342319000327/0000903423-19-000327-index.htm |
2020-06-23 | DRS | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1706431/000095012320006355/0000950123-20-006355-index.htm |
2019-11-08 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1706431/000107261319000288/0001072613-19-000288-index.htm |
2020-07-29 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1706431/000107261320000244/0001072613-20-000244-index.htm |
2019-10-11 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1706431/000119312519266864/0001193125-19-266864-index.htm |
2019-10-15 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1706431/000119312519267739/0001193125-19-267739-index.htm |
2019-10-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1706431/000119312519268465/0001193125-19-268465-index.htm |
2019-10-25 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1706431/000119312519274796/0001193125-19-274796-index.htm |
2020-01-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1706431/000119312520012408/0001193125-20-012408-index.htm |
2020-01-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1706431/000119312520018960/0001193125-20-018960-index.htm |
2020-02-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1706431/000119312520033376/0001193125-20-033376-index.htm |
2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1706431/000119312520038186/0001193125-20-038186-index.htm |
2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1706431/000119312520038518/0001193125-20-038518-index.htm |
2020-03-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1706431/000119312520067291/0001193125-20-067291-index.htm |
2020-03-26 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1706431/000119312520087036/0001193125-20-087036-index.htm |
2020-04-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1706431/000119312520098942/0001193125-20-098942-index.htm |
2020-04-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1706431/000119312520100575/0001193125-20-100575-index.htm |
2020-04-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1706431/000119312520103108/0001193125-20-103108-index.htm |
2020-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1706431/000119312520127710/0001193125-20-127710-index.htm |
2020-05-08 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1706431/000119312520137555/0001193125-20-137555-index.htm |
2020-05-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1706431/000119312520150065/0001193125-20-150065-index.htm |
2020-05-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1706431/000119312520155704/0001193125-20-155704-index.htm |
2020-06-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1706431/000119312520169350/0001193125-20-169350-index.htm |
2020-06-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1706431/000119312520174259/0001193125-20-174259-index.htm |
2020-07-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1706431/000119312520187279/0001193125-20-187279-index.htm |
2020-07-06 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1706431/000119312520187304/0001193125-20-187304-index.htm |
2020-07-06 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1706431/000119312520187358/0001193125-20-187358-index.htm |
2020-07-06 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1706431/000119312520187359/0001193125-20-187359-index.htm |
2020-07-07 | S-1MEF | Registration adding securities to prior Form S-1 registration [Rule 462(b)] | https://www.sec.gov/Archives/edgar/data/1706431/000119312520189005/0001193125-20-189005-index.htm |
2020-07-08 | POS EX | Post-effective amendment adding exhibits to registration statement [Rule 462(d)] | https://www.sec.gov/Archives/edgar/data/1706431/000119312520189006/0001193125-20-189006-index.htm |
2020-07-08 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1706431/000119312520189707/0001193125-20-189707-index.htm |
2020-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1706431/000119312520213032/0001193125-20-213032-index.htm |
2020-09-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1706431/000119312520237218/0001193125-20-237218-index.htm |
2020-09-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1706431/000119312520247168/0001193125-20-247168-index.htm |
2019-10-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919119052974/0001209191-19-052974-index.htm |
2019-10-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919119052975/0001209191-19-052975-index.htm |
2019-10-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919119052977/0001209191-19-052977-index.htm |
2019-10-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919119052978/0001209191-19-052978-index.htm |
2019-10-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919119052979/0001209191-19-052979-index.htm |
2019-10-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919119052981/0001209191-19-052981-index.htm |
2019-10-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919119053065/0001209191-19-053065-index.htm |
2019-10-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919119053066/0001209191-19-053066-index.htm |
2019-10-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919119053067/0001209191-19-053067-index.htm |
2019-10-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919119053661/0001209191-19-053661-index.htm |
2019-10-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919119053662/0001209191-19-053662-index.htm |
2019-10-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919119053663/0001209191-19-053663-index.htm |
2019-10-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919119053664/0001209191-19-053664-index.htm |
2019-10-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919119053665/0001209191-19-053665-index.htm |
2019-10-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919119053666/0001209191-19-053666-index.htm |
2019-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919119060214/0001209191-19-060214-index.htm |
2020-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120013608/0001209191-20-013608-index.htm |
2020-04-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120024672/0001209191-20-024672-index.htm |
2020-04-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120025177/0001209191-20-025177-index.htm |
2020-05-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120027256/0001209191-20-027256-index.htm |
2020-05-07 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120027806/0001209191-20-027806-index.htm |
2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120029859/0001209191-20-029859-index.htm |
2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120029879/0001209191-20-029879-index.htm |
2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120030596/0001209191-20-030596-index.htm |
2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120032059/0001209191-20-032059-index.htm |
2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120032060/0001209191-20-032060-index.htm |
2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120032061/0001209191-20-032061-index.htm |
2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120032062/0001209191-20-032062-index.htm |
2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120032063/0001209191-20-032063-index.htm |
2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120032064/0001209191-20-032064-index.htm |
2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120032065/0001209191-20-032065-index.htm |
2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120032066/0001209191-20-032066-index.htm |
2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120032330/0001209191-20-032330-index.htm |
2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120033779/0001209191-20-033779-index.htm |
2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120033780/0001209191-20-033780-index.htm |
2020-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120034452/0001209191-20-034452-index.htm |
2020-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120035975/0001209191-20-035975-index.htm |
2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120037646/0001209191-20-037646-index.htm |
2020-06-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120038510/0001209191-20-038510-index.htm |
2020-06-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120038511/0001209191-20-038511-index.htm |
2020-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120038791/0001209191-20-038791-index.htm |
2020-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120039103/0001209191-20-039103-index.htm |
2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120040660/0001209191-20-040660-index.htm |
2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120040662/0001209191-20-040662-index.htm |
2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120040664/0001209191-20-040664-index.htm |
2020-07-14 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120042452/0001209191-20-042452-index.htm |
2020-07-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120042454/0001209191-20-042454-index.htm |
2020-07-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120042489/0001209191-20-042489-index.htm |
2020-07-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120042652/0001209191-20-042652-index.htm |
2020-07-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120042653/0001209191-20-042653-index.htm |
2020-07-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120044060/0001209191-20-044060-index.htm |
2020-07-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120044076/0001209191-20-044076-index.htm |
2020-08-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120044531/0001209191-20-044531-index.htm |
2020-08-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120044534/0001209191-20-044534-index.htm |
2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120044748/0001209191-20-044748-index.htm |
2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120045688/0001209191-20-045688-index.htm |
2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120045693/0001209191-20-045693-index.htm |
2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120046369/0001209191-20-046369-index.htm |
2020-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120047942/0001209191-20-047942-index.htm |
2020-09-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120048971/0001209191-20-048971-index.htm |
2020-09-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120048972/0001209191-20-048972-index.htm |
2020-09-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120049394/0001209191-20-049394-index.htm |
2020-09-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120049397/0001209191-20-049397-index.htm |
2020-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120049967/0001209191-20-049967-index.htm |
2020-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120049970/0001209191-20-049970-index.htm |
2020-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120051170/0001209191-20-051170-index.htm |
2020-09-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120051679/0001209191-20-051679-index.htm |
2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120052221/0001209191-20-052221-index.htm |
2020-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120052656/0001209191-20-052656-index.htm |
2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120053260/0001209191-20-053260-index.htm |
2020-10-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120054284/0001209191-20-054284-index.htm |
2020-10-13 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120054735/0001209191-20-054735-index.htm |
2020-10-13 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120054736/0001209191-20-054736-index.htm |
2020-10-13 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120054737/0001209191-20-054737-index.htm |
2020-10-13 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120054738/0001209191-20-054738-index.htm |
2020-10-13 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120054739/0001209191-20-054739-index.htm |
2020-10-13 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120054740/0001209191-20-054740-index.htm |
2020-10-13 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120054741/0001209191-20-054741-index.htm |
2020-10-13 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120054742/0001209191-20-054742-index.htm |
2020-10-13 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120054743/0001209191-20-054743-index.htm |
2020-10-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120054833/0001209191-20-054833-index.htm |
2020-10-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120055604/0001209191-20-055604-index.htm |
2020-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120056143/0001209191-20-056143-index.htm |
2020-11-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120056681/0001209191-20-056681-index.htm |
2020-11-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1706431/000120919120057160/0001209191-20-057160-index.htm |
2020-05-04 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1706431/000138713120004398/0001387131-20-004398-index.htm |
2019-11-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1706431/000156459019043876/0001564590-19-043876-index.htm |
2019-11-19 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1706431/000156459019043877/0001564590-19-043877-index.htm |
2020-03-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1706431/000156459020013184/0001564590-20-013184-index.htm |
2020-03-26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1706431/000156459020013194/0001564590-20-013194-index.htm |
2020-04-06 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1706431/000156459020015537/0001564590-20-015537-index.htm |
2020-04-06 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1706431/000156459020015538/0001564590-20-015538-index.htm |
2020-05-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1706431/000156459020024651/0001564590-20-024651-index.htm |
2020-05-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1706431/000156459020024652/0001564590-20-024652-index.htm |
2020-08-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1706431/000156459020039291/0001564590-20-039291-index.htm |
2020-08-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1706431/000156459020039295/0001564590-20-039295-index.htm |
2020-05-08 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1706431/000178633520000001/0001786335-20-000001-index.htm |
2020-05-08 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1706431/000178633520000002/0001786335-20-000002-index.htm |
2019-10-10 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1706431/999999999519002288/9999999995-19-002288-index.htm |
2020-07-07 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1706431/999999999520001710/9999999995-20-001710-index.htm |
Vir Biotechnology, Inc (VIR) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vir Biotechnology, Inc (VIR). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1416%Institutional Ownership: 7961%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2020-05-14 | Herbert Virgin | EVP, Research & CSO | Sell | 3,805.00 | 30.07 | 114,418.25 | 0.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120029879/0001209191-20-029879-index.htm |
2020-05-18 | Herbert Virgin | EVP, Research & CSO | Sell | 1,755.00 | 38.00 | 66,690.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120030596/0001209191-20-030596-index.htm |
2020-05-26 | Herbert Virgin | EVP, Research & CSO | Sell | 3,805.00 | 34.08 | 129,674.40 | 0.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120032330/0001209191-20-032330-index.htm |
2020-06-09 | Herbert Virgin | EVP, Research & CSO | Sell | 3,805.00 | 36.28 | 138,030.18 | 0.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120035975/0001209191-20-035975-index.htm |
2020-06-19 | Herbert Virgin | EVP, Research & CSO | Sell | 1,755.00 | 38.00 | 66,690.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120038510/0001209191-20-038510-index.htm |
2020-06-23 | Herbert Virgin | EVP, Research & CSO | Sell | 5,560.00 | 38.99 | 216,777.73 | 0.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120038791/0001209191-20-038791-index.htm |
2020-06-24 | Herbert Virgin | EVP, Research & CSO | Sell | 9,360.00 | 48.00 | 449,280.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120038791/0001209191-20-038791-index.htm |
2020-07-14 | Herbert Virgin | EVP, Research & CSO | Sell | 7,900.00 | 48.85 | 385,876.29 | 0.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120042653/0001209191-20-042653-index.htm |
2020-07-28 | Herbert Virgin | EVP, Research & CSO | Sell | 7,900.00 | 47.99 | 379,090.19 | 0.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120044076/0001209191-20-044076-index.htm |
2020-08-11 | Herbert Virgin | EVP, Research & CSO | Sell | 7,900.00 | 51.08 | 403,562.81 | 0.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120046369/0001209191-20-046369-index.htm |
2019-10-16 | ARCH Venture Partners IX, LLC | 10% Share Holder | Buy | 1,000,000.00 | 20.00 | 20,000,000.00 | 1,000,000.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919119053664/0001209191-19-053664-index.htm |
2019-10-16 | Kristina Burow | Director | Buy | 1,000,000.00 | 20.00 | 20,000,000.00 | 1,000,000.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919119053666/0001209191-19-053666-index.htm |
2019-10-16 | ROBERT NELSEN | Director | Buy | 1,000,000.00 | 20.00 | 20,000,000.00 | 1,000,000.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919119053665/0001209191-19-053665-index.htm |
2020-04-17 | Phillip Pang | Chief Medical Officer | Buy | 8,000.00 | 0.86 | 6,840.00 | 15,777.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120025177/0001209191-20-025177-index.htm |
2020-06-03 | Phillip Pang | Chief Medical Officer | Sell | 7,500.00 | 35.06 | 262,932.00 | 15,777.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120034452/0001209191-20-034452-index.htm |
2020-06-17 | Phillip Pang | Chief Medical Officer | Sell | 7,500.00 | 37.26 | 279,472.50 | 15,777.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120037646/0001209191-20-037646-index.htm |
2020-07-01 | Phillip Pang | Chief Medical Officer | Sell | 5,000.00 | 37.77 | 188,840.50 | 15,777.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120040662/0001209191-20-040662-index.htm |
2020-07-15 | Phillip Pang | Chief Medical Officer | Sell | 7,500.00 | 49.52 | 371,435.25 | 15,777.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120042652/0001209191-20-042652-index.htm |
2020-08-05 | Phillip Pang | Chief Medical Officer | Sell | 7,500.00 | 50.89 | 381,695.25 | 15,777.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120045688/0001209191-20-045688-index.htm |
2020-05-18 | Herbert Virgin | EVP, Research & CSO | Buy | 1,755.00 | 1.53 | 2,685.15 | 1,755.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120030596/0001209191-20-030596-index.htm |
2020-06-19 | Herbert Virgin | EVP, Research & CSO | Sell | 1,755.00 | 38.00 | 66,694.04 | 1,755.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120038510/0001209191-20-038510-index.htm |
2020-07-13 | Howard Horn | CFO | Sell | 30,000.00 | 50.06 | 1,501,731.00 | 177,777.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120042489/0001209191-20-042489-index.htm |
2020-07-01 | Phillip Pang | Chief Medical Officer | Buy | 2,778.00 | 1.58 | 4,375.35 | 18,555.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120040662/0001209191-20-040662-index.htm |
2020-09-08 | Herbert Virgin | EVP, Research & CSO | Sell | 2,340.00 | 29.98 | 70,147.58 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120049970/0001209191-20-049970-index.htm |
2020-09-22 | Herbert Virgin | EVP, Research & CSO | Sell | 3,805.00 | 31.71 | 120,638.29 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120051679/0001209191-20-051679-index.htm |
2020-07-02 | Howard Horn | CFO | Sell | 10,000.00 | 40.00 | 400,000.00 | 207,777.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120040660/0001209191-20-040660-index.htm |
2020-07-01 | Howard Horn | CFO | Sell | 400.00 | 39.33 | 15,732.00 | 217,777.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120040660/0001209191-20-040660-index.htm |
2020-07-01 | Howard Horn | CFO | Sell | 500.00 | 38.78 | 19,392.00 | 218,177.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120040660/0001209191-20-040660-index.htm |
2020-07-01 | Howard Horn | CFO | Sell | 9,100.00 | 37.72 | 343,274.75 | 218,677.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120040660/0001209191-20-040660-index.htm |
2020-05-14 | Jay Parrish | Chief Business Officer | Sell | 75,000.00 | 30.05 | 2,253,885.00 | 222,222.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120029859/0001209191-20-029859-index.htm |
2020-06-01 | Jay Parrish | Chief Business Officer | Sell | 75,000.00 | 35.22 | 2,641,410.00 | 222,222.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120033780/0001209191-20-033780-index.htm |
2020-07-01 | Jay Parrish | Chief Business Officer | Sell | 75,000.00 | 37.95 | 2,846,310.00 | 222,222.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120040664/0001209191-20-040664-index.htm |
2020-08-03 | Jay Parrish | Chief Business Officer | Sell | 11,110.00 | 47.65 | 529,403.72 | 222,222.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120044748/0001209191-20-044748-index.htm |
2020-09-01 | Jay Parrish | Chief Business Officer | Sell | 6,943.00 | 39.15 | 271,796.23 | 222,222.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120049394/0001209191-20-049394-index.htm |
2020-10-01 | Jay Parrish | Chief Business Officer | Sell | 6,945.00 | 34.75 | 241,341.53 | 222,222.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120053260/0001209191-20-053260-index.htm |
2020-11-02 | Jay Parrish | Chief Business Officer | Sell | 6,944.00 | 31.27 | 217,152.77 | 222,222.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120056681/0001209191-20-056681-index.htm |
2020-09-08 | Herbert Virgin | EVP, Research & CSO | Sell | 1,465.00 | 30.00 | 43,950.00 | 22,340.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120049970/0001209191-20-049970-index.htm |
2019-10-16 | Endurance (Cayman) Ltd SVF | 10% Share Holder | Buy | 950,000.00 | 20.00 | 19,000,000.00 | 22,616,666.00 | https://www.sec.gov/Archives/edgar/data/1706431/000089924319025695/0000899243-19-025695-index.htm |
2020-11-02 | Jay Parrish | Chief Business Officer | Buy | 4,629.00 | 1.49 | 6,874.07 | 226,851.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120056681/0001209191-20-056681-index.htm |
2020-10-01 | Jay Parrish | Chief Business Officer | Buy | 4,630.00 | 1.49 | 6,875.55 | 226,852.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120053260/0001209191-20-053260-index.htm |
2020-06-25 | Howard Horn | CFO | Sell | 30,000.00 | 50.00 | 1,500,000.00 | 227,777.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120039103/0001209191-20-039103-index.htm |
2020-09-01 | Jay Parrish | Chief Business Officer | Buy | 6,943.00 | 1.58 | 10,935.23 | 229,165.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120049394/0001209191-20-049394-index.htm |
2020-11-02 | Jay Parrish | Chief Business Officer | Buy | 2,315.00 | 1.58 | 3,646.13 | 229,166.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120056681/0001209191-20-056681-index.htm |
2020-10-01 | Jay Parrish | Chief Business Officer | Buy | 2,315.00 | 1.58 | 3,646.13 | 229,167.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120053260/0001209191-20-053260-index.htm |
2020-08-03 | Jay Parrish | Chief Business Officer | Buy | 9,259.00 | 1.49 | 13,749.62 | 231,481.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120044748/0001209191-20-044748-index.htm |
2020-06-03 | Phillip Pang | Chief Medical Officer | Sell | 5,000.00 | 35.09 | 175,455.00 | 23,277.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120034452/0001209191-20-034452-index.htm |
2020-06-17 | Phillip Pang | Chief Medical Officer | Sell | 5,000.00 | 37.27 | 186,342.00 | 23,277.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120037646/0001209191-20-037646-index.htm |
2020-07-01 | Phillip Pang | Chief Medical Officer | Sell | 7,500.00 | 37.79 | 283,411.50 | 23,277.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120040662/0001209191-20-040662-index.htm |
2020-07-15 | Phillip Pang | Chief Medical Officer | Sell | 5,000.00 | 49.54 | 247,683.00 | 23,277.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120042652/0001209191-20-042652-index.htm |
2020-08-05 | Phillip Pang | Chief Medical Officer | Sell | 5,000.00 | 50.91 | 254,526.50 | 23,277.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120045688/0001209191-20-045688-index.htm |
2020-08-03 | Jay Parrish | Chief Business Officer | Buy | 1,851.00 | 1.58 | 2,915.33 | 233,332.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120044748/0001209191-20-044748-index.htm |
2020-09-24 | Herbert Virgin | EVP, Research & CSO | Buy | 3,700.00 | 1.53 | 5,661.00 | 23,700.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120052221/0001209191-20-052221-index.htm |
2020-09-29 | Herbert Virgin | EVP, Research & CSO | Sell | 3,510.00 | 38.00 | 133,380.00 | 23,700.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120052656/0001209191-20-052656-index.htm |
2020-10-13 | Herbert Virgin | EVP, Research & CSO | Sell | 5,560.00 | 43.03 | 239,236.24 | 23,700.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120054833/0001209191-20-054833-index.htm |
2020-10-27 | Herbert Virgin | EVP, Research & CSO | Sell | 3,805.00 | 35.04 | 133,334.81 | 23,700.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120056143/0001209191-20-056143-index.htm |
2020-09-08 | Herbert Virgin | EVP, Research & CSO | Buy | 3,805.00 | 1.53 | 5,821.65 | 23,805.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120049970/0001209191-20-049970-index.htm |
2020-09-22 | Herbert Virgin | EVP, Research & CSO | Buy | 3,805.00 | 1.53 | 5,821.65 | 23,805.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120051679/0001209191-20-051679-index.htm |
2020-07-01 | Jay Parrish | Chief Business Officer | Buy | 25,925.00 | 1.49 | 38,498.63 | 248,147.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120040664/0001209191-20-040664-index.htm |
2020-06-19 | Howard Horn | CFO | Sell | 10,000.00 | 40.00 | 400,000.00 | 257,777.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120038511/0001209191-20-038511-index.htm |
2020-08-19 | Phillip Pang | Chief Medical Officer | Buy | 10,185.00 | 1.58 | 16,041.38 | 25,962.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120047942/0001209191-20-047942-index.htm |
2020-07-15 | Phillip Pang | Chief Medical Officer | Buy | 10,186.00 | 1.58 | 16,042.95 | 25,963.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120042652/0001209191-20-042652-index.htm |
2020-06-01 | Howard Horn | CFO | Sell | 6,714.00 | 35.38 | 237,572.88 | 267,777.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120033779/0001209191-20-033779-index.htm |
2020-09-29 | Herbert Virgin | EVP, Research & CSO | Buy | 3,510.00 | 1.53 | 5,370.30 | 27,210.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120052656/0001209191-20-052656-index.htm |
2020-06-01 | Howard Horn | CFO | Sell | 3,286.00 | 34.53 | 113,465.25 | 274,491.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120033779/0001209191-20-033779-index.htm |
2020-10-27 | Herbert Virgin | EVP, Research & CSO | Buy | 3,805.00 | 1.53 | 5,821.65 | 27,505.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120056143/0001209191-20-056143-index.htm |
2020-06-03 | Phillip Pang | Chief Medical Officer | Buy | 12,500.00 | 5.18 | 64,687.50 | 28,277.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120034452/0001209191-20-034452-index.htm |
2020-06-17 | Phillip Pang | Chief Medical Officer | Buy | 12,500.00 | 5.18 | 64,687.50 | 28,277.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120037646/0001209191-20-037646-index.htm |
2020-07-01 | Phillip Pang | Chief Medical Officer | Buy | 9,722.00 | 5.18 | 50,311.35 | 28,277.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120040662/0001209191-20-040662-index.htm |
2020-07-15 | Phillip Pang | Chief Medical Officer | Buy | 2,314.00 | 5.18 | 11,974.95 | 28,277.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120042652/0001209191-20-042652-index.htm |
2020-08-05 | Phillip Pang | Chief Medical Officer | Buy | 12,500.00 | 1.58 | 19,687.50 | 28,277.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120045688/0001209191-20-045688-index.htm |
2020-08-19 | Phillip Pang | Chief Medical Officer | Buy | 2,315.00 | 5.18 | 11,980.13 | 28,277.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120047942/0001209191-20-047942-index.htm |
2020-10-13 | Herbert Virgin | EVP, Research & CSO | Buy | 5,560.00 | 1.53 | 8,506.80 | 29,260.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120054833/0001209191-20-054833-index.htm |
2020-05-14 | Jay Parrish | Chief Business Officer | Buy | 75,000.00 | 1.49 | 111,375.00 | 297,222.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120029859/0001209191-20-029859-index.htm |
2020-06-01 | Jay Parrish | Chief Business Officer | Buy | 75,000.00 | 1.49 | 111,375.00 | 297,222.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120033780/0001209191-20-033780-index.htm |
2020-07-01 | Jay Parrish | Chief Business Officer | Buy | 49,075.00 | 1.58 | 77,293.13 | 297,222.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120040664/0001209191-20-040664-index.htm |
2020-08-19 | Phillip Pang | Chief Medical Officer | Sell | 7,500.00 | 50.94 | 382,047.75 | 29,777.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120047942/0001209191-20-047942-index.htm |
2020-09-02 | Phillip Pang | Chief Medical Officer | Sell | 5,000.00 | 32.91 | 164,537.00 | 29,777.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120049397/0001209191-20-049397-index.htm |
2020-09-16 | Phillip Pang | Chief Medical Officer | Sell | 5,000.00 | 31.92 | 159,591.00 | 29,777.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120051170/0001209191-20-051170-index.htm |
2020-10-07 | Phillip Pang | Chief Medical Officer | Sell | 5,000.00 | 41.73 | 208,629.00 | 29,777.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120054284/0001209191-20-054284-index.htm |
2020-10-21 | Phillip Pang | Chief Medical Officer | Sell | 5,000.00 | 35.59 | 177,951.50 | 29,777.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120055604/0001209191-20-055604-index.htm |
2020-11-04 | Phillip Pang | Chief Medical Officer | Buy | 5,000.00 | 1.53 | 7,650.00 | 34,777.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120057160/0001209191-20-057160-index.htm |
2020-09-02 | Phillip Pang | Chief Medical Officer | Sell | 7,500.00 | 32.88 | 246,621.75 | 34,777.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120049397/0001209191-20-049397-index.htm |
2020-09-16 | Phillip Pang | Chief Medical Officer | Sell | 7,500.00 | 31.88 | 239,103.00 | 34,777.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120051170/0001209191-20-051170-index.htm |
2020-10-07 | Phillip Pang | Chief Medical Officer | Sell | 7,500.00 | 41.76 | 313,166.25 | 34,777.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120054284/0001209191-20-054284-index.htm |
2020-10-21 | Phillip Pang | Chief Medical Officer | Sell | 7,500.00 | 35.42 | 265,656.75 | 34,777.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120055604/0001209191-20-055604-index.htm |
2020-06-19 | Herbert Virgin | EVP, Research & CSO | Buy | 3,510.00 | 1.53 | 5,370.30 | 3,510.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120038510/0001209191-20-038510-index.htm |
2019-10-16 | Dhabi Investment Authority Abu | Insider | Buy | 1,000,000.00 | 20.00 | 20,000,000.00 | 3,666,666.00 | https://www.sec.gov/Archives/edgar/data/1706431/000090342319000327/0000903423-19-000327-index.htm |
2020-08-19 | Phillip Pang | Chief Medical Officer | Sell | 5,000.00 | 50.96 | 254,807.50 | 37,277.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120047942/0001209191-20-047942-index.htm |
2020-10-21 | Phillip Pang | Chief Medical Officer | Buy | 7,870.00 | 1.53 | 12,041.10 | 37,647.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120055604/0001209191-20-055604-index.htm |
2020-05-14 | Herbert Virgin | EVP, Research & CSO | Buy | 3,805.00 | 1.53 | 5,821.65 | 3,805.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120029879/0001209191-20-029879-index.htm |
2020-05-26 | Herbert Virgin | EVP, Research & CSO | Buy | 3,805.00 | 1.53 | 5,821.65 | 3,805.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120032330/0001209191-20-032330-index.htm |
2020-06-09 | Herbert Virgin | EVP, Research & CSO | Buy | 3,805.00 | 1.53 | 5,821.65 | 3,805.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120035975/0001209191-20-035975-index.htm |
2020-09-16 | Phillip Pang | Chief Medical Officer | Buy | 9,720.00 | 1.58 | 15,309.00 | 39,497.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120051170/0001209191-20-051170-index.htm |
2020-09-16 | Phillip Pang | Chief Medical Officer | Buy | 465.00 | 1.53 | 711.45 | 39,962.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120051170/0001209191-20-051170-index.htm |
2020-10-07 | Phillip Pang | Chief Medical Officer | Buy | 10,185.00 | 1.53 | 15,583.05 | 39,962.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120054284/0001209191-20-054284-index.htm |
2020-10-21 | Phillip Pang | Chief Medical Officer | Buy | 2,315.00 | 1.58 | 3,646.13 | 39,962.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120055604/0001209191-20-055604-index.htm |
2020-08-19 | Phillip Pang | Chief Medical Officer | Buy | 14,000.00 | 0.86 | 11,970.00 | 42,277.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120047942/0001209191-20-047942-index.htm |
2020-09-02 | Phillip Pang | Chief Medical Officer | Buy | 12,500.00 | 1.58 | 19,687.50 | 42,277.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120049397/0001209191-20-049397-index.htm |
2020-09-16 | Phillip Pang | Chief Medical Officer | Buy | 2,315.00 | 5.18 | 11,980.13 | 42,277.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120051170/0001209191-20-051170-index.htm |
2020-10-07 | Phillip Pang | Chief Medical Officer | Buy | 2,315.00 | 1.58 | 3,646.13 | 42,277.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120054284/0001209191-20-054284-index.htm |
2020-10-21 | Phillip Pang | Chief Medical Officer | Buy | 2,315.00 | 5.18 | 11,980.13 | 42,277.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120055604/0001209191-20-055604-index.htm |
2019-10-16 | Holdings (Private) Ltd Temasek | 10% Share Holder | Buy | 500,000.00 | 20.00 | 10,000,000.00 | 5,499,999.00 | https://www.sec.gov/Archives/edgar/data/1706431/000089924319025766/0000899243-19-025766-index.htm |
2019-10-16 | Permanent Fund Corp Alaska | 10% Share Holder | Buy | 1,500,000.00 | 20.00 | 30,000,000.00 | 5,555,556.00 | https://www.sec.gov/Archives/edgar/data/1706431/000089843219001253/0000898432-19-001253-index.htm |
2020-06-23 | Herbert Virgin | EVP, Research & CSO | Buy | 5,560.00 | 1.53 | 8,506.80 | 5,560.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120038791/0001209191-20-038791-index.htm |
2020-05-01 | ROBERT J MORE | Director | Sell | 2,700.00 | 28.60 | 77,212.44 | 71,534.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120027256/0001209191-20-027256-index.htm |
2020-05-01 | ROBERT J MORE | Director | Sell | 15,758.00 | 27.90 | 439,640.32 | 74,234.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120027256/0001209191-20-027256-index.htm |
2020-07-14 | Herbert Virgin | EVP, Research & CSO | Buy | 7,900.00 | 1.53 | 12,087.00 | 7,900.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120042653/0001209191-20-042653-index.htm |
2020-07-28 | Herbert Virgin | EVP, Research & CSO | Buy | 7,900.00 | 1.53 | 12,087.00 | 7,900.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120044076/0001209191-20-044076-index.htm |
2020-08-11 | Herbert Virgin | EVP, Research & CSO | Buy | 7,900.00 | 1.53 | 12,087.00 | 7,900.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120046369/0001209191-20-046369-index.htm |
2020-06-24 | Herbert Virgin | EVP, Research & CSO | Buy | 9,360.00 | 1.53 | 14,320.80 | 9,360.00 | https://www.sec.gov/Archives/edgar/data/1706431/000120919120038791/0001209191-20-038791-index.htm |